To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
Condition:   Gastric Cancer Interventions:   Drug: Patients who continued UDCA 300mg medication;   Other: Patients who discontinued UDCA 300mg prescription Sponsor:   Daewoong Pharmaceutical Co. LTD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2022 Category: Research Source Type: clinical trials